Review Article

A Review of the Gut-Uterine Axis in Persian Medicine Literature: Implications in Polycystic Ovary Syndrome


Persian medicine (PM) takes a holistic approach towards diagnosis and management of disease states, focusing on the connections between body systems and organs. Menstrual disorders are of utmost importance in women, as they may lead to dysfunctions in other body systems. Deeming a mutual relationship between the gastrointestinal and female reproductive systems, PM physicians believed in a gut-uterine axis to exist. Ehtebas-e Tams (ET), meaning menstrual retention, is not an exception, being accompanied by gastrointestinal morbidities including digestive disorders, nausea, heartburn, food craving and pica, reduced appetite, abdominal pain, and bloody diarrhea. Considering polycystic ovary syndrome (PCOS) as an instance of ET, we searched studies to investigate these correlations. While a number of the mentioned ET symptoms were confirmed by contemporary studies, others had not been investigated widely and are yet to be elucidated. Conducting studies to clarify such correlations has implications in improved diagnosis and novel modes of treatment.

Nelson LM. Primary ovarian insufficiency. New Engl J Med2009;360:606-614.

ACOG Committee Opinion No. 651: Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Obstet Gynecol 2015;126:e143-6.

Avicenna. Qanun Fi al-Teb (Canon of Medicine). Iran University of Medical Sciences, Institute of Medicine History, Islamic and Alternative Medicine. Tehran 2004.

Rezadoost H, Karimi M, Jafari M. Proteomics of hot-wet and cold-dry temperaments proposed in Iranian traditional medicine: a Network-based Study. Sci Rep 2016;6:1-8.

Arzani MA.Tebb-E Akbari. Iran University of Medical Sciences, Institute of Medicine History, Islamic and Alternative Medicine. Tehran 2005.

Zareian MA, Nejatbakhsh F, Yargholi A. Gut-Uterus Connection: The Path for Prevention of Pregnancy Complications. Trad Integr Med 2018;3:177-179.

Jorjani E. Zakhireh Kharazmshahi. Institute of Natural Medicine Restoration. Qom 2013.

Razhes MZ.Al-Havi fi Al-Tibb (Continens).Dare Ehya al-Toras Institute.Beirut 2001.

Tabari AS. Ferdows al-Hikmah fi al-Teb. Dar al-Kotob al-Elmiah. Beirut 2002.

Nazem Jahan MA. Exir-e A'zam (The Great Panacea). Iran University of Medical Sciences, Institute of Medicine History, Islamic and Alternative Medicine.Tehran 2008.

Hosseinkhani A, Asadi N, Pasalar M, Zarshenas MM. Traditional Persian Medicine and management of metabolic dysfunction in polycystic ovary syndrome. J Tradit Complement Med 2018;8:17-23.

Bahman M, Hajimehdipoor H, Afrakhteh M, Bioos S, Hashem-Dabaghian F, Tansaz M. The importance of sleep hygiene in polycystic ovary syndrome from the view of Iranian traditional medicine and modern medicine.Int J Prev Med 2018;9.

Bahman M, Tansaz M. A review on Iranian Traditional Medicine about Leech Therapy in Polycystic Ovary Syndrome. IJOGI 2019;22:75-84.

Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 2014;171:1-29.

Markopoulos MC, Valsamakis G, Kouskouni E, Boutsiadis A, Papassotiriou I, Creatsas G, Mastorakos G. Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause. Eur J Endocrinol 2012;168:83-90.

Schmidt J, Dahlgren E, Brännström M, Landin‐Wilhelmsen K. Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome–a long‐term follow‐up study. Clin Endocrinol (Oxf) 2012;77:207-214.

Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010;16:347-363.

Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 2012;33:981-1030.

Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 2011;95:1073-1079.

Toulis KA, Goulis DG, Mintziori G, Kintiraki E, Eukarpidis E, Mouratoglou SA, Pavlaki A, Stergianos S, Poulasouchidou M, Tzellos TG, Makedos A. Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome. Hum Reprod Update 2011;17:741-760.

Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association?Endocr Rev 2003;24:302-312.

GhaderiG. Fosoul Al-A'raaz (Commentary on Arzani's Book of Hodood Al-Amraz). Iran University of Medical Sciences, Institute of Medicine History, Islamic and Alternative Medicine. Tehran 2009.

HeraviM, Bahr al-Jawaher. Jalaluddin Publications. Qom 2008.

Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996;10:83-89.

Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479.

Tack J, Talley NJ. Functional dyspepsia—symptoms, definitions and validity of the Rome III criteria.Nat Rev Gastroenterol Hepatol 2013;10:134.

Tack J, Bisschops RA, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004;127:1239-1255.

Enck P, Azpiroz F, Boeckxstaens G, Elsenbruch S, Feinle-Bisset C, Holtmann G, Lackner JM, Ronkainen J, Schemann M, Stengel A, Tack J. Functional dyspepsia. Nat Rev Dis Primers 2017;3:1-20.

Tack J, Masaoka T, Janssen P. Functional dyspepsia. Curr Opin Gastroenterol 2011;27:549-557.

Camilleri M. Functional dyspepsia and gastroparesis. Dig Dis 2016;34:491-499.

Guo Y, Qi Y, Yang X, Zhao L, Wen S, Liu Y, Tang L. Association between polycystic ovary syndrome and gut microbiota. PloS one 2016;11:e0153196.

Kelley ST, Skarra DV, Rivera AJ, Thackray VG. The gut microbiome is altered in a letrozole-induced mouse model of polycystic ovary syndrome. PloS one 2016;11:e0146509.

Lindheim L, Bashir M, Münzker J, Trummer C, Zachhuber V, Leber B, Horvath A, Pieber TR, Gorkiewicz G, Stadlbauer V, Obermayer-Pietsch B. Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): a pilot study. PloS one 2017;12:e0168390.

Zhang D, Zhang L, Yue F, Zheng Y, Russell R. Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation. Eur J Endocrinol 2015;172:29-36.

Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet–induced obesity and diabetes in mice. Diabetes 2008;57:1470-1481.

Mirbagheri SA, Khajavirad N, Rakhshani N, Ostovaneh MR, Hoseini SM, Hoseini V. Impact of Helicobacter pylori infection and microscopic duodenal histopathological changes on clinical symptoms of patients with functional dyspepsia. Dig Dis Sci 2012;57:967-972.

Yavaşoglu I, Küçük M. Anti-Helicobacter pylori antibodies and polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2012;163:243.

Sohrabvand F, Shariat M, Farahvash MJ, Haghollahi F, Khosravi M, Maasomi M, Bagheri M, Abdollahi A, Sarbiyaie A, Bashari F. Serological study of Helicobacter pylori infection in patients with Polycystic Ovary Syndrome. Tehran Univ Med J 2014;71:660-664.

Tokmak A, Doğan Z, Sarıkaya E, Timur H, Kekilli M. Helicobacter pylori infection and polycystic ovary syndrome in adolescent and young adult patients. J Obstet Gynaecol Res 2016;42:1768-1772.

Zeng F, Qin W, Liang F, Liu J, Tang Y, Liu X, Yuan K, Yu S, Song W, Liu M, Lan L. Abnormal resting brain activity in patients with functional dyspepsia is related to symptom severity. Gastroenterology 2011;141:499-506.

Van Oudenhove L, Vandenberghe J, Dupont P, Geeraerts B, Vos R, Dirix S, Bormans G, Vanderghinste D, Van Laere K, Demyttenaere K, Fischler B. Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H215O-PET study.Am J Gastroenterol 2010;105:913-924.

Aro P, Talley NJ, Ronkainen J, Storskrubb T, Vieth M, Johansson SE, Bolling–Sternevald E, Agréus L. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology 2009;137:94-100.

Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2017;32:1075-1091.

Avicenna. Al-Shifa (Al-Tabieiaat). Ayatollah Marashi Najafi Library. Qom 1985.

Woywodt A, Kiss A. Geophagia: the history of earth-eating. J R Soc 2002;95:143-146.

AhvaziAA. Kamel al-Sana'a al-Tebbiya. Jalaluddin Publications, Institute of Natural Medicine Restoration. Qom 2008.

KermaniNE. Sharh al-Asbab va al-Alaamaat. Jalaluddin Publications, Institute of Natural Medicine Restoration. Qom 2008.

TabarraiM, EftekharT, NazemE.Letter to editor: Etiology of the Vaginal, Cervical, and Uterine Laceration on Avicenna Viewpoints. Iran J Public Health 2013;42:927-928.

Weingarten HP, Elston D. Food cravings in a college population. Appetite 1991;17:167-175.

Gendall KA, Joyce PR, Sullivan PF. Impact of definition on prevalence of food cravings in a random sample of young women. Appetite 1997;28:63-72.

Rodríguez-Martín BC, Meule A. Food craving: new contributions on its assessment, moderators, and consequences. Front Psychol 2015;6:21.

Morosi A, Jeanes Y. Food cravings, binge eating and emotional eating behaviours in overweight and obese women with polycystic ovary syndrome. Proc Nutr Soc 2017;76:E15.

Jeanes YM, Reeves S, Gibson EL, Piggott C, May VA, Hart KH. Binge eating behaviours and food cravings in women with polycystic ovary syndrome. Appetite 2017;109:24-32.

Balserak BI, Jackson N, Ratcliffe SA, Pack AI, Pien GW. Sleep-disordered breathing and daytime napping are associated with maternal hyperglycemia. Sleep Breath 2013;17:1093-1102.

Algars M, Huang L, Von Holle AF, Peat CM, Thornton LM, Lichtenstein P, Bulik CM. Binge eating and menstrual dysfunction. J Psychosom Res 2014;76:19-22.

Karacan E, Caglar GS, Gürsoy AY, Yilmaz MB. Body satisfaction and eating attitudes among girls and young women with and without polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2014;27:72-77.

Michelmore KF, Balen AH, Dunger DB. Polycystic ovaries and eating disorders: are they related?. Hum Reprod 2001;16:765-769.

Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil steril 2007;87:1369-1376.

Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil steril 2009;91:207-212.

Bernadett M, Szemán-N A. Prevalence of eating disorders among women with polycystic ovary syndrome. Psychiatr Hung 2016;31:136-145.

Arusoglu G, Koksal G, Cinar N, Tapan S, Aksoy DY, Yildiz BO. Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive. J Clin Endocrinol Metab 2013;98:4475-4482.

Linden Hirschberg A, Naessen S, Stridsberg M, Byström B, Holte J. Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome. Gynecol Endocrinol 2004;19:79-87.

Yadav A, Kataria MA, Saini V, Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 2013;417:80-84.

Gregoraszczuk EL, Rak A. Superactive human leptin antagonist reverses leptin-induced excessive progesterone and testosterone secretion in porcine ovarian follicles by blocking leptin receptors. J Physiol Pharmacol 2015;66:39-46.

Ram MR, Sundararaman PG, Malathi R. Body fat distribution and leptin correlation in women with polycystic ovary syndrome: Endocrine and biochemical evaluation in south Indian population. Reprod Med Biol 2005;4:71-78.

Rizk NM, Sharif E. Leptin as well as free leptin receptor is associated with polycystic ovary syndrome in young women. Int J Endocrinol 2015;2015:927805.

Sepilian VP, Crochet JR, Nagamani M. Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens. Fertil steril 2006;85:1441-1447.

Donath MY, Burcelin R. GLP-1 effects on islets: hormonal, neuronal, or paracrine?. Diabetes care 2013;36:S145-148.

Ozgen Saydam B, O Yildiz B. Gut-brain axis and metabolism in polycystic ovary syndrome. Curr Pharm Des 2016;22:5572-5587.

Aydin K, Cinar N, Aksoy DY, Bozdag G, Yildiz BO. Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination. Contraception 2013;87:358-362.

Lin T, Li S, Xu H, Zhou H, Feng R, Liu W, Sun Y, Ma J. Gastrointestinal hormone secretion in women with polycystic ovary syndrome: an observational study. Hum Reprod 2015;30:2639-2644.

Dockray GJ. Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 2012;19:8-12.

Linden Hirschberg A, Naessen S, Stridsberg M, Byström B, Holte J. Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome. Gynecol Endocrinol 2004;19:79-87.

Baranowska B, Radzikowska M, Wasilewska-Dziubińska E, Kapliński A, Roguski K, Płonowski A. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Gynecol Endocrinol999;13:344-351.

Vincent RP, Le Roux CW. The satiety hormone peptide YY as a regulator of appetite. J Clin Pathol 2008;61:548-552.

Zwirska-Korczala K, Sodowski K, Konturek SJ, Kuka D, Kukla M, Brzozowski T, Cnota W, Woźniak-Grygiel E, Jaworek J, Bułdak R, Rybus-Kalinowska B. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome. J Physiol Pharmacol 2008;59:161-178.

Moran LJ, Noakes M, Clifton PM, Wittert GA, Tomlinson L, Galletly C, Luscombe ND, Norman RJ. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab 2004;89:3337-3344.

ZahrawiKA. Kitab Al-Tasrif. Kuwait Foundation for the Advancement of Sciences. Kuwait 2004.

Gottschau M, Kjaer SK, Jensen A, Munk C, Mellemkjaer L. Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study. Gynecol Oncol 2015;136:99-103.

Sukocheva OA, Li B, Due SL, Hussey DJ, Watson DI. Androgens and esophageal cancer: What do we know?. World J Gastroenterol 2015;21:6146.

Lope V, de Larrea NF, Pérez-Gómez B, Martín V, Moreno V, Costas L, Longo F, Jiménez-Moleón JJ, Llorca J, Ascunce N, Peiró-Pérez R. Menstrual and reproductive factors and risk of gastric and colorectal cancer in Spain. PloS one 2016;11:e0164620.

Nieman KM, Romero IL, Van Houten B, Lengyel E. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 2013;1831:1533-1541.

Komninou D, Ayonote A, Richie Jr JP, Rigas B. Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood) 2003;228:396-405.

Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer—mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 2014;10:455.

IssueVol 5, No 1, 2020 QRcode
SectionReview Article(s)
Persian medicine; Iranian traditional medicine; Menstrual disorders; Gut-uterine axis; Functional dyspepsia; Eating disorders

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Naghizadeh A, Zareian MA, Tabarrai M. A Review of the Gut-Uterine Axis in Persian Medicine Literature: Implications in Polycystic Ovary Syndrome. Trad Integr Med. 2020;5(1):26-35.